abagovomab 33
abciximab 25
abituzumab 12
abrilumab 12
actoxumab 17
adalimumab 9
aducanumab 11
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 27
alirocumab 14
amatuximab 32
andecaliximab 17
anifrolumab 22
anrukinzumab 13
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 13
ascrinvacumab 3
atezolizumab 10
atinumab 12
avelumab 13
basiliximab 31
bavituximab 25
begelomab 20
benralizumab 19
bevacizumab_beta 16
bezlotoxumab 17
bimagrumab 10
bleselumab 15
blinatumomab 29
blosozumab 25
bococizumab 19
brazikumab 14
brentuximab_vedotin 22
briakinumab 14
brodalumab 10
brolucizumab 20
brontictuzumab 22
burosumab 18
cabiralizumab 22
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 30
carlumab 14
carotuximab 8
cergutuzumab_amunaleukin2 28
cergutuzumab_amunaleukin 28
certolizumab_pegol 22
cetiximab 28
citatuzumab_bogatox 24
cixutumumab 20
clivatuzumab_tetraxetan 14
codrituzumab 19
conatumumab 13
concizumab 14
crenezumab 14
crizanlizumab 19
crotedumab 18
dacetuzumab 21
daclizumab 12
dalotuzumab 18
dapirolizumab_pegol 25
daratumumab 12
dectrekumab 8
demcizumab 23
denosumab 7
depatuxizumab 15
depatuxizumab_mafodotin 15
dezamizumab 16
dinutuximab 29
diridavumab 11
domagrozumab 11
drozitumab 17
duligotuzumab 20
durvalumab 13
dusigitumab 23
efalizumab 33
efungumab 17
eldelumab 17
elezanumab 15
elgemtumab 4
elotuzumab 14
emactuzumab 15
emapalumab 18
emibetuzumab 19
enavatuzumab 23
enfortumab_vedotin 10
enoblituzumab 17
enokizumab 23
enoticumab 18
ensituximab 24
eptinezumab 9
erenumab 21
etaracizumab 12
etrolizumab 19
evinacumab 17
evolocumab 16
farletuzumab 0
fasinumab 20
fezakinumab 18
fibatuzumab 11
ficlatuzumab 25
firivumab 25
flanvotumab 18
fletikumab 31
foralumab 14
foravirumab 14
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 14
galcanezumab 12
ganitumab 17
gantenerumab 14
gemetuzumab 26
gemtuzumab2 23
gemtuzumab 12
gevokizumab 15
girentuximab 23
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 17
ibalizumab 22
ibritumomab 28
icrucumab 14
idarucizumab 24
ifabotuzumab 11
imalumab 11
imgatuzumab 21
inclacumab 15
indatuximab_ravtansin 27
indusatumab 16
inebilizumab 20
intetumumab 12
iodine_girentuximab 20
ipilimumab 4
iratumumab 12
isatuximab 26
itolizumab 17
ixekizumab 20
labetuzumab_govitecan 23
lambrolizumab 24
lampalizumab 26
lanadelumab 19
landogrozumab 15
laprituximab 25
lebrikizumab 23
lendalizumab 26
lenzilumab 18
lifastuzumab_vedotin 15
ligelizumab 15
lilotomab 30
lirilumab 19
lodelcizumab 13
lokivetmab 11
lorvotuzumab_mertansin 14
lucatumumab 26
lumretuzumab 18
lupartumab 13
lutikizumab 12
margetuximab 30
milatuzumab 18
mirvetuximab 32
mirvetuximab_soravtansin 32
modotuximab 32
mogamulizumab 17
monalizumab 22
motavizumab 27
moxetumomab_pasudotox 14
namilumab 18
naratuximab 26
naratuximab_emtansin 26
narnatumab 15
navicixizumab2 26
navicixizumab 23
navivumab 14
necitumumab 9
nemolizumab 25
nesvacumab 14
nivolumab 14
obiltoxaximab 16
obinutuzumab 24
ocaratuzumab 21
ofatumumab 13
olaratumab 11
olokizumab 19
omalizumab 16
onartuzumab 22
ontuxizumab 18
opicinumab 13
orticumab 6
otelixizumab 25
oxelumab 8
ozanezumab 17
pamrevlumab 7
panobacumab 18
parsatuzumab 27
pasotuxizumab 16
pateclizumab 15
patritumab 15
pembrolizumab 24
perakizumab 20
pidilizumab 13
pinatuzumab_vedotin 14
plozalizumab 13
pogalizumab 23
polatuzumab_vedotin 17
ponezumab 23
prezalumab 14
pritoxaximab 30
quilizumab 15
racotumomab 22
radretumab 11
ralpancizumab 23
ramucirumab 8
ranevetmab 29
ranibizumab 13
refanezumab 17
remtolumab 10
rilotumumab 17
rinucumab 6
risankizumab 28
rituximab 13
rivabazumab 23
robatumumab 19
roledumab 17
romosozumab 18
rontalizumab 22
rosmantuzumab 14
rozanolixizumab 18
sacituzumab 28
sacituzumab_govitecan 28
samalizumab 22
sapelizumab 18
sarilumab 9
secukinumab 17
seribantumab 16
setoxaximab 29
sifalimumab 10
siltuximab 7
simtuzumab 25
sirukumab 9
solanezumab 22
solitomab 22
stamulumab 16
suptavumab 24
suvizumab 16
tabalumab 11
tadocizumab 14
tamtuvetmab 26
tanezumab 19
tarextumab 9
tavolixizumab 8
telisotuzumab 24
teplizumab 15
tesidolumab 20
tezepelumab 25
tigatuzumab 13
tildrakizumab 17
timolumab 11
tisotumab 9
tosatoxumab 23
tositumomab 25
tralokinumab 28
trastuzumab 25
tregalizumab 18
trevogrumab 8
ublituximab 25
urelumab 14
ustekinumab 22
utomilumab 20
vadastuximab 18
vadastuximab_talirin 18
vandortuzumab_vedotin 18
vantictumab 24
vanucizumab2 16
vanucizumab 21
varlilumab 18
vatelizumab 11
vedolizumab 11
veltuzumab 12
vesencumab 8
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 28
xentuzumab 17
zatuximab 32
